BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12:585-603. [PMID: 14567019 DOI: 10.1016/s1055-3207(03)00026-7] [Cited by in Crossref: 155] [Cited by in F6Publishing: 36] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Rabie ME, Al Shraim M, Al Skaini MS, Alqahtani S, El Hakeem I, Al Qahtani AS, Malatani T, Hummadi A. Mucus containing cystic lesions "mucocele" of the appendix: the unresolved issues. Int J Surg Oncol 2015;2015:139461. [PMID: 25878899 DOI: 10.1155/2015/139461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
2 Liang L, Zhou N, Xu H, Liu D, Lu Y, Li F, Guo J. Urachal mucinous adenocarcinoma with pseudomyxoma peritonei: A case report. Medicine (Baltimore) 2017;96:e7548. [PMID: 28858081 DOI: 10.1097/MD.0000000000007548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pillai K, Akhter J, Morris DL. Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: an ex vivo and in vitro study. Pleura Peritoneum 2017;2:111-7. [PMID: 30911639 DOI: 10.1515/pp-2017-0013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
4 Yang SY, Kang JH, Kim HS, Han YD, Min BS, Lee KY. Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. J Gastrointest Oncol 2019;10:1251-65. [PMID: 31949946 DOI: 10.21037/jgo.2019.01.36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Schattner A, Gotler J. Scalloping of the Liver. J Gen Intern Med 2015;30:1884-5. [PMID: 25740461 DOI: 10.1007/s11606-014-3157-6] [Reference Citation Analysis]
6 Llueca A, Serra A, Maiocchi K, Delgado K, Jativa R, Gomez L, Escrig J. Predictive model for major complications after extensive abdominal surgery in primary advanced ovarian cancer. Int J Womens Health 2019;11:161-7. [PMID: 30881145 DOI: 10.2147/IJWH.S190493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Roy A, Stanford S, Nunn S, Alves S, Sargant N, Rangarajan S, Smith EA, Bell J, Dayal S, Cecil T, Tzivanakis A, Kruzhkova I, Solomon C, Knaub S, Moran B, Mohamed F. Efficacy of fibrinogen concentrate in major abdominal surgery - A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei. J Thromb Haemost 2020;18:352-63. [PMID: 31654548 DOI: 10.1111/jth.14665] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Bevan KE, Mohamed F, Moran BJ. Pseudomyxoma peritonei. World J Gastrointest Oncol 2010; 2(1): 44-50 [PMID: 21160816 DOI: 10.4251/wjgo.v2.i1.44] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 58] [Article Influence: 5.4] [Reference Citation Analysis]
9 Sinukumar S, Mehta S, As R, Damodaran D, Ray M, Zaveri S, Kammar P, Bhatt A. Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO. Indian J Surg Oncol 2019;10:65-70. [PMID: 30886496 DOI: 10.1007/s13193-018-00870-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Guo AT, Song X, Wei LX, Zhao P. Histological origin of pseudomyxoma peritonei in Chinese women: Clinicopathology and immunohistochemistry. World J Gastroenterol 2011; 17(30): 3531-3537 [PMID: 21941421 DOI: 10.3748/wjg.v17.i30.3531] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
11 Qu ZB, Liu LX. Management of pseudomyxoma peritonei. World J Gastroenterol 2006; 12(38): 6124-6127 [PMID: 17036382 DOI: 10.3748/wjg.v12.i38.6124] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
12 Sugarbaker PH. Surgical management of carcinomatosis from colorectal cancer. Clin Colon Rectal Surg. 2005;18:190-203. [PMID: 20011302 DOI: 10.1055/s-2005-916280] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
13 Zhou S, Zhao H, He X. The Prognostic Impact of Pathology on Patients With Pseudomyxoma Peritonei Undergoing Debulking Surgery: A Systematic Review and Meta-Analysis of Retrospective Studies. Front Surg 2020;7:554910. [PMID: 33304920 DOI: 10.3389/fsurg.2020.554910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Han XD, Zhou N, Lu YY, Xu HB, Guo J, Liang L. Pseudomyxoma peritonei originating from intestinal duplication: A case report and review of the literature. World J Clin Cases 2021; 9(25): 7459-7467 [PMID: 34616812 DOI: 10.12998/wjcc.v9.i25.7459] [Reference Citation Analysis]
15 Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM, Camp RL. Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg 2006;244:52-60. [PMID: 16794389 DOI: 10.1097/01.sla.0000217617.06782.d5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
16 Heiskala K, Giles-Komar J, Heiskala M, Andersson LC. High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei. Virchows Arch. 2006;448:295-300. [PMID: 16323007 DOI: 10.1007/s00428-005-0105-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
17 Chen P, Su L, Yang W, Zhang J, Wang Y, Wang C, Yu Y, Yang L, Zhou Z. Development and validation of prognostic nomograms for pseudomyxoma peritonei patients after surgery: A population-based study. Medicine (Baltimore) 2020;99:e20963. [PMID: 32756083 DOI: 10.1097/MD.0000000000020963] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg. 2006;243:212-222. [PMID: 16432354 DOI: 10.1097/01.sla.0000197702.46394.16] [Cited by in Crossref: 346] [Cited by in F6Publishing: 306] [Article Influence: 23.1] [Reference Citation Analysis]
19 Pillai K, Akhter J, Chua TC, Morris DL. Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei. Invest New Drugs 2012;30:2080-6. [PMID: 22359216 DOI: 10.1007/s10637-012-9797-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
20 Haase E, Yoo D, Sugarbaker PH. Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy. World J Surg Oncol 2009;7:48. [PMID: 19454019 DOI: 10.1186/1477-7819-7-48] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
21 Joo MW, Chung YG, Hur SY, Lee A, Jung CK, Jee WH, Kim JH. Pseudomyxoma peritonei extending to the lower extremity: a case report. World J Surg Oncol 2015;13:221. [PMID: 26187269 DOI: 10.1186/s12957-015-0639-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Hirano M, Yonemura Y, Canbay E, Ichinose M, Togawa T, Matsuda T, Takao N, Mizumoto A. Laparoscopic Diagnosis and Laparoscopic Hyperthermic Intraoperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Detected by CT Examination. Gastroenterol Res Pract. 2012;2012:741202. [PMID: 22956941 DOI: 10.1155/2012/741202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
23 Khan AB, Al Suhaibani Y, Al Mohaimed K, Morris DL. Application of advanced multimodality care to pseudomyxoma peritonei patient: report of first patient treated at a tertiary center. Indian J Surg Oncol 2010;1:270-3. [PMID: 22693376 DOI: 10.1007/s13193-010-0036-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Youssef H, Moran BJ. On or in the liver? Two cases with diffuse pseudomyxoma peritonei and synchronous hepatic pathology. Tech Coloproctol 2011;15:85-7. [PMID: 21249511 DOI: 10.1007/s10151-010-0671-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Lansom J, Alzahrani N, Liauw W, Morris DL. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours. Indian J Surg Oncol 2016;7:166-76. [PMID: 27065707 DOI: 10.1007/s13193-015-0478-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
26 Idris LO, Olaofe OO, Adejumobi OM, Kolawole AO, Jimoh AK. Giant mucocele of the appendix in pregnancy: A case report and review of literature. Int J Surg Case Rep 2015;9:95-7. [PMID: 25744561 DOI: 10.1016/j.ijscr.2015.02.042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Chua TC, Liauw W, Morris DL. Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis 2012;27:381-9. [PMID: 21853235 DOI: 10.1007/s00384-011-1303-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
28 Liang L, Fang J, Han X, Zhai X, Song Y, Lu Y, Zhang Q, Ma R. Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei. Front Oncol 2021;11:594763. [PMID: 34733775 DOI: 10.3389/fonc.2021.594763] [Reference Citation Analysis]
29 Kuijpers AM, Aalbers AG, Nienhuijs SW, de Hingh IH, Wiezer MJ, van Ramshorst B, van Ginkel RJ, Havenga K, Heemsbergen WD, Hauptmann M. Implementation of a standardized HIPEC protocol improves outcome for peritoneal malignancy. World J Surg. 2015;39:453-460. [PMID: 25245434 DOI: 10.1007/s00268-014-2801-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
30 Emam E, Ghanim A, Ghanim A. Pseudomyxoma peritonei with endometrial mucinous carcinoma and appendicular mucinous tumor: An unusual association. J Microsc Ultrastruct 2016;4:6-10. [PMID: 30023204 DOI: 10.1016/j.jmau.2015.08.002] [Reference Citation Analysis]
31 陈小明, 彭光喜, 徐正水, 应家祺, 程华. 原发性阑尾黏液腺癌1例. 世界华人消化杂志 2015; 23(16): 2677-2680 [DOI: 10.11569/wcjd.v23.i16.2677] [Reference Citation Analysis]
32 Campanati RG, Hanan B, de Souza SS, Gomes da Silva R. Pregnancy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei. Case Rep Surg 2014;2014:694912. [PMID: 25013738 DOI: 10.1155/2014/694912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Ramaswamy V. Pathology of mucinous appendiceal tumors and pseudomyxoma peritonei. Indian J Surg Oncol. 2016;7:258-267. [PMID: 27065718 DOI: 10.1007/s13193-016-0516-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
34 Sheehan LA, Mehta AM, Sawan S, Dayal SP, Mohamed F, Moran BJ, Cecil TD. Preserving fertility in pseudomyxoma peritonei, a novel approach. Pleura Peritoneum 2017;2:33-6. [PMID: 30911630 DOI: 10.1515/pp-2016-0024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Pillai K, Akhter J, Mekkawy A, Chua TC, Morris DL. Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP). Int J Med Sci 2017;14:18-28. [PMID: 28138305 DOI: 10.7150/ijms.16422] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
36 Suh DS, Song YJ, Kwon BS, Lee S, Lee NK, Choi KU, Kim KH. An unusual case of pseudomyxoma peritonei associated with synchronous primary mucinous tumors of the ovary and appendix: A case report.Oncol Lett. 2017;13:4813-4817. [PMID: 28599482 DOI: 10.3892/ol.2017.6079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhong Y, Deng M, Xu R, Kokudo N, Tang W. Pseudomyxoma peritonei as an intractable disease and its preoperative assessment to help improve prognosis after surgery: A review of the literature. Intractable Rare Dis Res 2012;1:115-21. [PMID: 25343082 DOI: 10.5582/irdr.2012.v1.3.115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
38 Nikiforchin A, Gushchin V, Sittig M, Baron E, Lopez-Ramirez F, Nieroda C, Sardi A. Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases. Ann Surg Oncol 2021. [PMID: 34546479 DOI: 10.1245/s10434-021-10669-9] [Reference Citation Analysis]